N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state
Background: Psychoactive serotonin 5-HT2A receptor agonists are potent modulators of awareness. Influential theories propose that psychedelics alter whole-brain dynamics by increasing neural signal diversity and dynamic flexibility. Beyond temporal variability, it is an open question whether psychedelics impact the characteristics of transient neural state sequences themselves. Aims: Our goal was to assess how an ayahuasca-inspired formulation (intranasal N,N-Dimethyltryptamine (DMT) and buccal harmine) modulates parameters of neural state sequences close to the peak of the psychedelic state. Methods: In a double-blind, randomised, placebo-controlled Electroencephalography (EEG) study, participants ( n = 25) were administered the following interventions on separate testing days: (1) a DMT/harmine formulation; (2) harmine alone and (3) a placebo. We used EEG microstate analysis to compare the neural dynamics between the three conditions. Results/Outcomes: Compared to harmine and placebo, DMT/harmine was linked to reduced microstate duration but increased microstate occurrence and complexity. Higher first-order Markov statistics revealed that transition sequences became less random when DMT/harmine was administered. Conclusions/Interpretation: Our finding that DMT/harmine is associated with more complex and predictable neural state sequences as well as accelerated state transitions is consistent with models of increased metastability and signal diversity. By revealing a more diverse repertoire of neural state sequences under DMT/harmine, our findings improve our understanding of neural dynamics in psychedelic states. Clinical trial registration: Neurodynamics of prosocial emotional processing following serotonergic stimulation with N,N-DMT and harmine in healthy subjects. https://clinicaltrials.gov/ct2/show/NCT04716335 .
Authors
- Helena Aicher (ORCID: https://orcid.org/0000-0001-5915-7086)
- Dila Suay (ORCID: https://orcid.org/0000-0002-5268-9992)
- Maria Niedernhuber (ORCID: https://orcid.org/0000-0002-4459-6796)
- Milan Scheidegger (ORCID: https://orcid.org/0000-0003-1313-2208)
- Bigna Lenggenhager
- Dario Dornbierer
- Michael Müller
Institutions
- University of Zurich (CH)
- University of Cambridge (GB)
- ETH Zurich (CH)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2026-09-22
- DOI
- https://doi.org/10.1177/02698811261481062
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00